HPR141 Modelling the Impact of Pricing Exceptions and Protections on Pharmaceutical Expenditure in Greece

Abstract

Authors

K Souliotis P Golnas D Theodoratou C Golna

Full Text Cite This Article
Back to Volume 25, Supplemental Issue 12S
Your browser is out-of-date

ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now

×